Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Derek D. Poore"'
Autor:
David J Rickard, Clark A Sehon, Viera Kasparcova, Lorena A Kallal, Pamela A Haile, Xin Zeng, Monica N Montoute, Derek D Poore, Hu Li, Zining Wu, Patrick M Eidam, John G Emery, Robert W Marquis, Peter J Gough, John Bertin
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96737 (2014)
NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria. Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a
Externí odkaz:
https://doaj.org/article/d8966b29a270430a972aa590bfa33f4f
Autor:
David J Rickard, Clark A Sehon, Viera Kasparcova, Lorena A Kallal, Xin Zeng, Monica N Montoute, Tushar Chordia, Derek D Poore, Hu Li, Zining Wu, Patrick M Eidam, Pamela A Haile, Jong Yu, John G Emery, Robert W Marquis, Peter J Gough, John Bertin
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e69619 (2013)
NOD2 is an intracellular pattern recognition receptor that assembles with receptor-interacting protein (RIP)-2 kinase in response to the presence of bacterial muramyl dipeptide (MDP) in the host cell cytoplasm, thereby inducing signals leading to the
Externí odkaz:
https://doaj.org/article/5e593a2a329d48da9774642aa0357266
Autor:
Hu Li, Hongwei Qi, Brian Donovan, Ming Jiang, Derek D. Poore, Zining Wu, Michael Fischer, Subhas J. Chakravorty, Lawrence Wolfe, Thomas D. Sweitzer, Glenn A. Hofmann
Publikováno v:
SLAS discovery : advancing life sciences RD. 24(2)
Nrf2, a master regulator of the phase II gene response to stress, is kept at low concentrations in the cell through binding to Keap1, an adaptor protein for the Cul3 ubiquitin ligase complex. To identify Nrf2 activators, two separate time-resolved fl
Autor:
Derek D Poore, Pallavi Deshpande, Andrew J. Gee, Tara S. Carpenter, David J. Merkler, Mitchell E. Johnson
Publikováno v:
Journal of Chromatography B. 809:15-21
Primary fatty acid amides (R-CO-NH2) and N-acylglycines (R-CO-NH-CH2-COOH) are classes of compounds that have only recently been isolated and characterized from biological sources. Key questions remain regarding how these lipid amides are produced an
Autor:
David J. Merkler, Derek D Poore, Geoffrey H. Chew, Lamar Galloway, Kathleen A. Merkler, Cheol Hwan Yoon, Mitchell Anthony Delong, Advait S. Nagle, Kyung Woon Jung, Laura Aaron Miller, Laura E. Baumgart
Publikováno v:
Archives of Biochemistry and Biophysics. 412:3-12
The C-terminal α-amide moiety of most peptide hormones arises by the posttranslational cleavage of a glycine-extended precursor in a reaction catalyzed by bifunctional peptidylglycine α-amidating monooxygenase (PAM). Glutathione and the S -alkylate
Autor:
Monica N. Montoute, Robert W. Marquis, Tushar Chordia, Jun Yu, Zining Wu, Clark A. Sehon, Peter J. Gough, Xin Zeng, Lorena A. Kallal, Patrick M. Eidam, Viera Kasparcova, David J. Rickard, Pamela A. Haile, Derek D. Poore, Hu Li, John Bertin, John G. Emery
Publikováno v:
PLoS ONE
PLoS ONE, Vol 8, Iss 8, p e69619 (2013)
PLoS ONE, Vol 8, Iss 8, p e69619 (2013)
NOD2 is an intracellular pattern recognition receptor that assembles with receptor-interacting protein (RIP)-2 kinase in response to the presence of bacterial muramyl dipeptide (MDP) in the host cell cytoplasm, thereby inducing signals leading to the
Autor:
Monica N. Montoute, Zining Wu, John G. Emery, Pamela A. Haile, Derek D. Poore, John Bertin, Peter J. Gough, Lorena A. Kallal, Clark A. Sehon, Xin Zeng, Hu Li, Viera Kasparcova, David J. Rickard, Robert W. Marquis, Patrick M. Eidam
Publikováno v:
PLoS ONE, Vol 9, Iss 5, p e96737 (2014)
PLoS ONE
PLoS ONE
NOD1 is an intracellular pattern recognition receptor that recognizes diaminopimelic acid (DAP), a peptidoglycan component in gram negative bacteria. Upon ligand binding, NOD1 assembles with receptor-interacting protein (RIP)-2 kinase and initiates a
Autor:
Grandhi TSP; Complex In-Vitro Models, GSK, Collegeville, PA, United States of America., Mebrahtu M; Genome Biology, GSK, Collegeville, PA, United States of America., Musso R; Genome Biology, GSK, Collegeville, PA, United States of America., Fullman A; Genome Biology, GSK, Collegeville, PA, United States of America., Nifong B; Research Statistics, GSK, Collegeville, PA, United States of America., Wisdom K; Complex In-Vitro Models, GSK, Collegeville, PA, United States of America., Roh TT; Complex In-Vitro Models, GSK, Collegeville, PA, United States of America., Sender M; Chemical Biology, GSK, Collegeville, PA, United States of America., Poore D; Immuno-Oncology and Combinations (IOC), GSK, Collegeville, PA, United States of America., Macdougall CE; Oncology Cell Therapy, GSK, Stevenage, United Kingdom., Oren R; Oncology Cell Therapy, GSK, Stevenage, United Kingdom., Griffin S; Oncology Translational Research, GSK, Stevenage, United Kingdom., Cheng AT; Genome Biology, GSK, Collegeville, PA, United States of America., Ekert JE; Complex In-Vitro Models, GSK, Collegeville, PA, United States of America.
Publikováno v:
Biofabrication [Biofabrication] 2024 Oct 24; Vol. 17 (1). Date of Electronic Publication: 2024 Oct 24.
Lung tumor microphysiological system with 3D endothelium to evaluate modulators of T-cell migration.
Autor:
Wisdom KM; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Suijker J; Mimetas B.V., Oegstgeest, The Netherlands., Van den Broek L; Mimetas B.V., Oegstgeest, The Netherlands., Sridharan B; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Grandhi TSP; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Cheng A; Genomic Sciences, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Lamb M; Genomic Sciences, Research, Pharmaceutical R&D, GSK, Stevenage, UK., Titus SA; Genomic Sciences, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Poore D; Immuno-Oncology, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Shah N; Immuno-Oncology, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Cheng SH; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Kim E; Immuno-Oncology, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA., Griffin S; Immuno-Oncology, Research, Pharmaceutical R&D, GSK, Stevenage, UK., Ekert J; In Vitro In Vivo Translation, Research, Pharmaceutical R&D, GSK, Collegeville, PA, USA.
Publikováno v:
ALTEX [ALTEX] 2023; Vol. 40 (4), pp. 649-664. Date of Electronic Publication: 2023 Jun 16.